Endometriosis Trial, Recruiting NCT05779462 Sponsor: University Hospital, Lille Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT05779462
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been referred by a doctor because pelvic endometriosis is suspected and you need a pelvic MRI scan
  • You are female and have never given birth
  • You are willing to sign a consent form agreeing to take part in the study
  • You have health insurance coverage
  • You are willing and able to follow all study procedures for the full duration of the trial

Who may not be able to join:

  • Your Body Mass Index (BMI) is over 35 (this is a measure of body weight relative to height)
  • You have a personal history of an inherited condition affecting connective tissue (such as conditions affecting collagen or elastic tissue in the body) (confirm with trial site)
  • You have a history of a serious infection or inflammation affecting the pelvis and abdomen (known as pelviperitonitis)
  • You have previously had major surgery in the pelvic area
  • You are unable to understand and receive information about the study
  • You are unable to take part in the full duration of the study
  • You do not have social security coverage
  • You do not wish to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chrystele RUBOD, MD,PhD, University Hospital, Lille

Phone: 0320445962

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 May 2023
Est. completion
1 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

the mean vertical displacement (in millimeters) measured on the anterior wall of the vagina between rest and maximum pushing force during dynamic MRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov